BIVI: Gunggung utang perusahaan BioVie Pharma

The aggregate debt load of BioVie Inc. (BIVI) correlates with the implementation of IT modeling for compounds targeting dementia and cirrhosis, with 0.00 serving as the current parameter value. The company develops advanced molecules for cellular metabolism correction, leveraging a stable legal framework in the US and Europe to minimize external political risks.

BioVie Inc - Utang perusahaan BIVI (periode 04.07.2022 - 28.10.2026)

Rincian analitis lan laporan data perusahaan BioVie Inc. (BIVI)

- rega lan prakiraan konsensus rega:

Bagan owah-owahan rega biovieinc.com|BIVI - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar BioVie Pharma|BIVI - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi Saham BioVie|BIVI - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih biovieinc.com|BIVI - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal BioVie Inc.|BIVI - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal biovieinc.com|BIVI - Utang perusahaan|Rasio utang marang kapitalisasi buku BioVie Pharma|BIVI - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak BioVie

Analisis fundamental perusahaan:BIVI BioVie Inc

This indicator measures the total volume of borrowed funds, allowing investors to assess financial stability and default risk through leverage dynamics. When analyzing the debt load metric, one should seek a balance between solvency and growth rates, which is critical for BioVie Inc. (BIVI) when financing the implementation of automated laboratory screening systems and predictive data analysis.

Pesaing wigati

Kewajiban utang agregat Arrowhead Corp (ARWR)|Gunggung utang perusahaan MIRM (Mirum Pharmaceuticals)|Dynavax Pharma - Gunggung utang perusahaan|Utang perusahaan Arbutus Biopharma Corporation (ABUS)|IVA: Kewajiban utang agregat|GYRE (Gyre Corp) - Utang perusahaan|Assembly Corp (ASMB) - Gunggung utang perusahaan|GALT (Galectin Therapeutics, Inc.) - Gunggung utang perusahaan|Gunggung utang perusahaan Genfit Corp (GNFT)|DURECT Corporation (DRRX) - Gunggung utang perusahaan|Kewajiban utang agregat ALGS (aligos.com)|Utang perusahaan Galmed Pharmaceuticals Ltd. GLMD|Utang perusahaan ENDRA Corp NDRA|Gunggung utang perusahaan HEPA (Hepion Pharma)